Filing Details
- Accession Number:
- 0001209191-20-036726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-15 18:00:06
- Reporting Period:
- 2020-06-15
- Accepted Time:
- 2020-06-15 18:00:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1700225 | J. Vincent Angotti | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-15 | 7,547 | $1.33 | 468,757 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Balance includes non-reportable acquisition of 8,318 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
